Roivant Sciences
Reinventing the discovery, development, and commercialization of new medicines
- Headquarters
- New York, New York
- Employees
- 201–500
- Founded
- 2014
- Website
- roivant.com
- Total Funding
- $200.0M
- Valuation
- $7.0BNov 2018
- Last Round
- $200.0M Venture RoundNov 2018
About
Roivant Sciences is a biotech holding company that aims to improve health by rapidly delivering innovative medicines and technologies to patients. It builds agile, focused companies called Vants across multiple therapeutic areas.
Sign up to view funding chart
Create a free account to see funding visualizations and detailed round data.
Create Free AccountFunding History
Sign up to view funding details
Create a free account to see full funding history, valuations, and investor participation.
Create Free Account